Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution

@inproceedings{Cho2009ManagementOO,
  title={Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution},
  author={Hyung Chan Cho and Kenneth Joel Wolf and Eric Jay Wolf},
  booktitle={Clinical ophthalmology},
  year={2009}
}
Recently, several new ophthalmic NSAID products have been introduced for commercial use in the United States. The purpose of this review is to briefly overview the ophthalmic NSAIDs currently in use and to discuss the management of postoperative ocular inflammation and pain following cataract surgery with a particular focus on bromfenac ophthalmic solution 0.09%. Bromfenac ophthalmic solution 0.09% is indicated for the reduction of ocular pain and inflammation following cataract surgery… CONTINUE READING
28 Citations
78 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 78 references

Xibrom (bromfenac) reduces cystoid macular edema associated with vein occlusions, macular epiretinal membrane, diabetic retinopathy and age related macular degeneration

  • JG Gross
  • Poster F-3 presented at: Annual Meeting of the…
  • 2009
1 Excerpt

Similar Papers

Loading similar papers…